chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headaches; joint pain; tiredness; fatigue; feeling in a haze/brain fog; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 10Apr2021 at 13:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to strawberries. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously took allopurinol and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 14:00, the patient experienced headaches, joint pain, tiredness, fatigue and felt haze/brain fog. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headaches, joint pain, tiredness, fatigue and felt haze/brain fog were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Seen in office on 5/2/07 due to hive like rash on arms, face 1 hour after receiving Menactra on 5/1/07 Benadryl given with relief of rash. Rash reoccurred 5/2/07. NO SOB, no wheeze.
knee swelling; pain in knee; total knee replacement; postoperative complication; Circulatory disorder peripheral; numbness; tingling; pain; This spontaneous case was reported by a physician and describes the occurrence of JOINT SWELLING (knee swelling), KNEE ARTHROPLASTY (total knee replacement), ARTHRALGIA (pain in knee), POST PROCEDURAL COMPLICATION (postoperative complication) and PERIPHERAL VASCULAR DISORDER (Circulatory disorder peripheral) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for an unknown indication.    The patient's past medical history included Cigarette smoker (Smoker/ Half of pack of cigarette per day) from 1957 to 1981, Alcohol use (Occasional Alcohol use, might be three times a years) and Knee replacement (Left knee replaced). Concomitant products included GABAPENTIN and IBUPROFEN for an unknown indication.   On 06-Jan-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. In 2020, the patient experienced PAIN (pain). On 09-Sep-2020, the patient experienced KNEE ARTHROPLASTY (total knee replacement). In September 2020, the patient experienced POST PROCEDURAL COMPLICATION (postoperative complication), PERIPHERAL VASCULAR DISORDER (Circulatory disorder peripheral), HYPOAESTHESIA (numbness) and PARAESTHESIA (tingling). On an unknown date, the patient experienced JOINT SWELLING (knee swelling) and ARTHRALGIA (pain in knee). At the time of the report, JOINT SWELLING (knee swelling), KNEE ARTHROPLASTY (total knee replacement), ARTHRALGIA (pain in knee), POST PROCEDURAL COMPLICATION (postoperative complication), HYPOAESTHESIA (numbness), PARAESTHESIA (tingling) and PAIN (pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test:.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information was unknown.  The action taken with mRNA-1273 in response to the events were not applicable.
FAST HEART RATE; DIZZINESS; SHORTNESS OF BREATH; BLURRED VISION; WEAKNESS; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on SEP-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On SEP-2021, the patient experienced fast heart rate. On SEP-2021, the patient experienced dizziness. On SEP-2021, the patient experienced shortness of breath. On SEP-2021, the patient experienced blurred vision. On SEP-2021, the patient experienced weakness. On SEP-2021, the patient experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fast heart rate, dizziness, weakness, blurred vision, headache, and shortness of breath. This report was non-serious.
approx 24hr p/vax started feeling weak & just not feeling well overall;c/o chills, gen weakness nausea-vomited x 's 1;rash appeared on both arm noc of 6APR97;pt still has sl rash @ 9AM 7APR97;also has hard knot @ inj site;
11 days after administration, patient presented with fussiness, decreased muscle tone, choreiform movements, patient initially treated with acyclovir until herpes ruled out. 3 weeks after onset of symptoms choreiform movements persist. 02/27/07-records received from facility for DOS 1/11-1/17/07 DC DX:altered mental status, hypotonia, choreo-athetotic movements.  HX:One week of altered mental status and seizure activity. Usual state of health until 1/6/07- Korean supplement  used in her food "Green Mineral Powder". URI two weeks parior to admission.
This spontaneous report as received from a medical assistant, refers to a female patient of currently 50 years old with amoxicillin allergy. The patient had no pertinent medical history. Medical assistant reported that the patient with an unknown vaccination history for measles, mumps, and rubella had negative titers for measles, mumps, and rubella when she was tested. Concomitant medications were not reported. The outcome of negative titers for measles, mumps, and rubella was not reported. No treatment was given for negative titers for measles, mumps, and rubella. Patient sought medical attention: Office visit. Additional information has been requested.
Pt going overseas, had typhoid inj. 27Jan12, felt fine, 2 days later while standing at sink numbness in face, tingling in fingers, & unsteady, legs went out from underneath him - went to - then to med ctr. Admitted MRI, CT scan, Labs, & LP - sx resolved & D/C from hospital - Pt had typhoid inj. in 2005 without difficulties.
headache; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 23rd August 2021, the patient received Shingles vaccine. In August 2021, less than a week after receiving Shingles vaccine, the patient experienced headache. On an unknown date, the outcome of the headache was unknown.   It was unknown if the reporter considered the headache to be related to Shingles vaccine.  Additional details were provided as follows: The patient reported the case for herself/himself. The age at vaccination was not reported. The patient received shingle shot and experienced big headache now but mentioned that, it was worth it to prevent shingles The follow up would not be possible as no contact details were available.
This spontaneous report as received from a healthcare worker refers to a patient of unknown demographics. No current conditions was reported. No pertinent medical history was reported. On 02-SEP-2014, the patient was vaccinated with (Oka/Merck) VARIVAX, .5 ml, subcutaneous. No concomitant medication was reported. On 02-SEP-2014, the patient received improperly stored VARIVAX, exposed to 23F for 3 hours. No adverse effects were reported. The outcome of patient received improperly stored VARIVAX was unknown. No further information was provided. No PQC was involved. This is one of the several reports. Additional information has been requested.
Feeling anxious, blood pressure 175/90, heart rate 120, she also had a busy hectic shift.  After being held for 1 hour, she went home, showered, and bp and hr returned to normal.
I had fatigue; fever (100.8); nausea; lose of appetite; cough - started when I got up on Friday, March 19th and lasted until Monday morning, March 22nd.  I felt like I had COVID all over again.
Initial information received on 14-Nov-2018 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 58 years old female patient who had an allergic reaction/red spots on both arms, while she received vaccine ADACEL. The patient's past medical history included Allergy to Thimerosal (Chemical). The patient's past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications were none. On 18-Oct-2018, the patient received a 0.5 ml dose of suspect ADACEL (lot C5228AA and expiration date 26-Jun-2019) via intramuscular route in the left arm. On an unknown date, patient developed a non-serious allergic reaction/red spots on both arms (hypersensitivity)(erythema) (latency was unknown) following the administration of ADACEL. On 20-Oct-2018, the patient visited doctor for red spots on both arm. No lab data was reported. Final diagnosis was she had an allergic reaction/red spots on both arms. It was not reported if the patient received a corrective treatment. The outcome was Unknown for she had an allergic reaction/red spots on both arms. List of documents held by sender: none.
I had pericarditis after my second Moderna shot and it had cleared up. The pericarditis recurred after this Pfizer booster. Symptoms were pressure in upper middle chest and trouble lying down to sleep. Inflammation was seen in blood work to confirm the diagnosis that the pericarditis had returned. I am on a 3-month course of high dose ibuprofen and colchicine for treatment.
pt recv vax; anaphylactic rxn to vax w/ post residual flaccid paralysis at both limbs; GBS, liver necrosis;still in tx;CPK=inc 2000 units; liver enzymes inc; protein dec eosinophils inc;
The pt experienced a red knot on the thigh, felt like a golf ball. On 4/21/01 the pt was seen in the ER for increased swelling and fever of 100.2. Exam revealed a 12 x 10 cm erythematous area on the anterior aspect of the right thigh. R/O infection at vax site versus delayed allergic reaction. Given IV Rocephin. Given Benadryl.
Admitted for stroke, also positive for Covid. Elevated CRP and D-dimer, infectious disease consulted, treated with Decadron and heparin.
Information has been received from a nurse practitioner concerning a 14 year old female who "sometime this month" was vaccinated with the first dose of GARDASIL vaccine. Subsequently the patient fainted. At time of the report the patient was recovered. The patient sought medical attention: the patient was in the clinic when AE occurred. Additional information has been requested.This is in follow-up to report (s) submitted on 2/13/2009. Follow-up informatin was received from the medical assistant. It was reported the 24 year old (previously reported as "14 year old") patient with drug hypersensitivity to condeine (reported as "codine") was vaccinated intramusculary into the left deltoid with the first dose of GARDASIL (lot # 661703/0651X) at 14:00 (reported as "2:00 pm") on 15-Jan-2009 1 - 2 minutes after receiving GARDASIL the patient had twitching and fainting episode. The patient regained consciousness after 1 to 2 minutes. She did not remember passing out. She claimed she had not eaten since the night before. She was given some cookies and water and observed. On that same date, the patient recovered. No further information was available.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Dec2021 at 13:30 as dose number unknown (booster), single (Lot number: FE3594) at the age of 64 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing); "GERD" (unspecified if ongoing); "vitamin D deficiency" (unspecified if ongoing); "overweight" (unspecified if ongoing); "depression" (unspecified if ongoing). Concomitant medication(s) included: VALSARTAN; WELLBUTRIN; OMEPRAZOLE; VITAMIN D [COLECALCIFEROL]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; MIRALAX. Past drug history included: Dilaudid, reaction(s): "Known allergies: Dilaudid". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: The patient received COVID 19 treatment with Paxlovid on 17Jul2022 and stopped on 22Jul2022 (Lot number: 2815223). It was reported that, covid symptoms returned 2-3 days after completing 5-day Paxlovid. coughing, scratchy throat, deep voice, body aches, runny nose. Not as severe as before. No follow-up attempts are possible. No further information is expected.
Tightness in throat, hives, itching, flushed, panic, cough. Epi 0.3mg administrered at 10:15 AM. Benadryl 50mg IM administered approx. 10:30AM. Nebulizer Albuterol treatment @ 10:45am. Transported to Medical Center via EMS.
This spontaneous report was received from a medical assistant, referring to a multiple unspecified patients of unknown ages and genders. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unknown date, the patients were vaccinated with and incorrect stored dose of VAQTA lot # N005274 with expiration date on 03-APR-2018 (strength and route were not reported) for prophylaxis, however no adverse effects reported. It was reported that the vaccines were exposed to temperature of 47 Fahrenheit grades range for a time frame of 1 hour and 15 minutes. The temperature excursion was recorded by a data logger and no previous excursions were reported for the vaccines. There was no product quality complaint involved. This is one of the several reports received from the same reporter.
Severe bruising to hands and arms when handling books.  Skin VERY black and blue for 7 to 10 days, then went away.  Possible it could be side effect of PRRT, as I had a little bit of bruising immediately after my 1st and 3rd PRRT treatments, but they were MUCH milder and took at least 4 weeks to go away.  This time it was SEVERE bruising and happened 6 weeks after PRRT but only 4 weeks after COVID vaccine.  And went away fairly quickly.
parents stated pt recvd vax & had dec movement starting day a/yesterday;yesterday would not move it @ all;states p/shot had temp;arm bruised & cried 1st day;no hx recent temp or trauma; arm does not look swollen;pt cries when arm touched
Patient felt feverish, started coughing, had cold like symptoms, severe headache. Stated that face swelled and felt swelling of the tongue and throat. Now feels like she has a sinus infection.
This spontaneous report was received from a pharmacist referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history, drug reaction/allergies or concomitant medication was not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX lot # M027117 with expiration date: 26-JUL-2017 (route and dosage schedule were not reported) for prophylaxis. The administered doses of vaccine were exposed to 18.27 Fahrenheit for an unspecified amount of time. Data logger was involved and there was no previous temperature excursion reported. There were no adverse effects reported. There was no Product Quality Complaint (PQC) involved. Additional information has been requested.
HPI: Pt is a 67 year old male without significant pmhx who presents with c/o numbness/tingling in his legs and arms for the past 4 days. He has also noted weakness in his legs and difficulty going up and down stairs. He also c/o some difficulty with balance.  He has almost fallen but not quite. He denies recent f/c/viral/n/v/d. He had a varicella zoster vaccine June 12th 2007. He was seen in the ED yesterday-he had a MRI brain without significant abnormaility.  He decided to come here     rather than be admitted in another state.  He came straight to ED from the airplane.  Patient was treated with IVIG 30 gm IV daily for 2 days for suspected Guillen-Barre ataxia.  8/31/07 Reviewed hospital medical records which reveal patient experienced numbness/tingling of legs & arms x 4 days, weakness of legs & difficulty w/stairs & balance.  Seen in out of state ER & then returned home to be admitted.  Had received vax due to outbreak of shingles in his domestic partner.  Patient denied any recent illness.  Exam revealed paresthesias of arms/legs w/associated weakness more proximally in quads & triceps.  Areflexia.  Neuro consult done.  LP done.  Admitted 7/24-7/27/07. Tx w/IVIG x 2 days & d/c to home w/outpatient PT.  Did not do well at home, had multiple falls, back/buttock pain, chest pressure & was readmitted to hospital 8/2/07. Neuro exam revealed mild diffuse facial diparesis & ataxia.  Plasmapheresis recommended & dialysis cath placed 8/7/07.  FINAL DX: Guillian Barre syndrome, w/relapse. No hospital d/c summary for either admit  11/05/07 Received additional hospital medical records which reveal patient was readmitted to hospital 8/2-8/13/2007 for worsening ataxia, LE weakness, falls x 2 & progressive UE weakness as well as LBP.  No d/c summary available but progress notes provided.  Neuro consult done & was areflexic throughout w/left ptosis & left facial droop as well.  Plasmapheresis X 5 done w/improvement but continued CN deficits & weakness.  Transferred to long term rehab. FINAL DX: Buillian Barre syndrome w/relapse.
chest pain (next day p/inj); swelling, redness & pain lt arm (inj site);
Injection site pain; Tiredness; Headache; Muscle pain; Chills; I have fever 100.3; Injection site is swelling; injection site have redness; feeling unwell; This is a spontaneous report from a contactable Nurse (patient). The patient received first dose of bnt162b2 (BNT162B2, lot number: EH9899, Expiry Date: Mar2021), unknown on 19Dec2020 18:00 at single dose for covid-19 immunisation. Medical history was reported as Patient History: No. There were no concomitant medications. Nurse stated, "I have received the vaccine, the Pfizer COVID vaccine yesterday at 06:00 PM. I have side effects is injection site pain, tiredness, headache, muscle pain, chills and I have fever 100.3 (I got the fever after 24 hours of receiving the vaccine) and injection site is swelling, injection site have redness and feeling unwell. I would like to know how long it takes to, the side effects is going to be gone." The outcome of the events was unknown.
Had a fever of 104. Was very tired and not responsive. Was taken to ER and given meds.
Information has been received from a physician referring to a male patient of unknown age. The patient's pertinent medical history and concurrent condition were not reported. On an unspecified date of 2012, the patient was vaccinated with his first dose of GARDASIL (dose, route and lot# were not reported). 1 year later after the first dose, on an unspecified date of 2013, route and lot# were not reported)(inappropriate schedule of drug administration). Then, 1 month after the second dose, the patient received his third dose of GARDASIL (dose, route and lot# were not reported) (inappropriate schedule of drug administration). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Chills, fatigue, sneezing, coughing, all lasting 7 days. Bed rest, zinc tablets, extra water. Only the coughing and some sneezing continue to this day, 11/11/2021.  The side effects from the first two vaccine doses were very mild and short lived compared to this Booster dose.
Experienced a full-blown period after 3.25 years of post-menopause.
Fevers, chills, erythema at injection site. Dx: cellulitis. Tx - KEFLEX 500mg PO 4 caps x10d.
Patient suffered sudden sensorineural hearing loss in right ear within hours of vaccination. On audiometry, right ear pure tone average declined from baseline of 31 dB to 64 dB, word recognition score from 88% to 44%. No vertigo.
Caller indicates husband received first dose 19JAN2021.  He was to receive second dose 09FEB2021, tested positive for SArS-Cov-2 06FEB2021; Caller indicates husband received first dose 19JAN2021.  He was to receive second dose 09FEB2021, tested positive for SArS-Cov-2 06FEB2021; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch/Lot number was not reported) first dose via an unspecified route of administration on 19Jan2021 as single dose for COVID-19 immunization. The patient medical history included vascular graft from an unknown date. The patient concomitant medications were not reported. The patient experienced that receiving of first dose on 19Jan2021 He was to receive second dose 09Feb2021, tested positive for SArS-Cov-2 06Feb2021. The customer stated that symptom like free-ish. Wanted to go to today for second dose.  Says he has a history of double bypass. Looking for extended information. Potential AE. the outcome of the event was unknown.  Information about lot/batch number is requested.  Follow-up attempts are completed. No further information is expected.
Patient alerted team to feeling dizzy and left neck muscles tight 5 mins after arriving in recover area.  Recovery RN assisted patient to bench area to lay down.  Vitals signs obtained (stable but patient states BP runs low, no rash or hives, color pink.  Patient lied down for approximately 30 mins.  Felt better, denies dizziness.  Left neck remains "sore".  Patient has boyfriend at home to watch her, was advised to call 911 or primary care if any reaction after leaving.
inappropiate schedule of product administration; This spontaneous report was received from a pharmacist concerning to a female patient of an unknown age .   The patient's medical history, concurrent conditions and concomitant therapies were not provided.     On an unspecified date between February or March 2020, the patient was vaccinated with the first dose hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, frequency, route, lot#, expiration date) for prophylaxis.  At the reporting time, the patient got vaccinated with her second dose (inappropriate schedule of product administration).